Human induced pluripotent stem cell-based microphysiological tissue models of myocardium and liver for drug development

Drug discovery and development to date has relied on animal models, which are useful but are often expensive, slow, and fail to mimic human physiology. The discovery of human induced pluripotent stem (iPS) cells has led to the emergence of a new paradigm of drug screening using human and disease-specific organ-like cultures in a dish. Although classical static culture systems are useful for initial screening and toxicity testing, they lack the organization of differentiated iPS cells into microphysiological, organ-like structures deemed necessary for high-content analysis of candidate drugs. One promising approach to produce these organ-like structures is the use of advanced microfluidic systems, which can simulate tissue structure and function at a micron level, and can provide high-throughput testing of different compounds for therapeutic and diagnostic applications. Here, we provide a brief outline on the different approaches, which have been used to engineer in vitro tissue constructs of iPS cell-based myocardium and liver functions on chip. Combining these techniques with iPS cell biology has the potential of reducing the dependence on animal studies for drug toxicity and efficacy screening.

[1]  Kumaraswamy Nanthakumar,et al.  Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue , 2009, Proceedings of the National Academy of Sciences.

[2]  Lucas H. Hofmeister,et al.  Scaling and systems biology for integrating multiple organs-on-a-chip. , 2013, Lab on a chip.

[3]  Liang Guo,et al.  Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  Mehmet Toner,et al.  Hepatic tissue engineering for adjunct and temporary liver support: critical technologies. , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells From Adult Human Fibroblasts by Defined Factors , 2008 .

[6]  Joseph P Vacanti,et al.  Hepatic tissue engineering. , 2004, Transplant immunology.

[7]  Ali Khademhosseini,et al.  Hydrogel-coated microfluidic channels for cardiomyocyte culture. , 2013, Lab on a chip.

[8]  Megan L. McCain,et al.  Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip. , 2011, Lab on a chip.

[9]  N. Bursac,et al.  Cardiomyocyte Cultures With Controlled Macroscopic Anisotropy: A Model for Functional Electrophysiological Studies of Cardiac Muscle , 2002, Circulation research.

[10]  G. Whitesides,et al.  Muscular Thin Films for Building Actuators and Powering Devices , 2007, Science.

[11]  W. Zimmermann,et al.  Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. , 2000, Biotechnology and bioengineering.

[12]  Kevin Kit Parker,et al.  Generation of Functional Ventricular Heart Muscle from Mouse Ventricular Progenitor Cells , 2009, Science.

[13]  Andre Levchenko,et al.  Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs , 2009, Proceedings of the National Academy of Sciences.

[14]  D. Solís US Food and Drug Administration , 2010 .

[15]  Wenming Liu,et al.  Investigation of hypoxia-induced myocardial injury dynamics in a tissue interface mimicking microfluidic device. , 2013, Analytical chemistry.

[16]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[17]  D. Mooney,et al.  Highly porous polymer matrices as a three-dimensional culture system for hepatocytes. , 1997, Cell transplantation.

[18]  Hollow fiber bioartificial liver utilizing collagen-entrapped porcine hepatocyte spheroids. , 1996 .

[19]  E. Entcheva,et al.  Electrospun fine-textured scaffolds for heart tissue constructs. , 2005, Biomaterials.

[20]  S. Yamanaka,et al.  The Use of Induced Pluripotent Stem Cells in Drug Development , 2011, Clinical pharmacology and therapeutics.

[21]  Sean P. Palecek,et al.  Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.

[22]  Matthew H. M. Lim,et al.  Perfused multiwell plate for 3D liver tissue engineering. , 2010, Lab on a chip.

[23]  Luke P. Lee,et al.  An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture. , 2007, Biotechnology and bioengineering.

[24]  Thomas Eschenhagen,et al.  Three‐dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  Luke P. Lee,et al.  Continuous perfusion microfluidic cell culture array for high-throughput cell-based assays. , 2005, Biotechnology and bioengineering.

[26]  Luke P. Lee,et al.  A novel high aspect ratio microfluidic design to provide a stable and uniform microenvironment for cell growth in a high throughput mammalian cell culture array. , 2005, Lab on a chip.

[27]  Jeffrey T Borenstein,et al.  Microfabrication of three-dimensional engineered scaffolds. , 2007, Tissue engineering.

[28]  Gwo-Bin Lee,et al.  Microfluidic cell culture systems for drug research. , 2010, Lab on a chip.

[29]  L. Reid Stem cell biology, hormone/matrix synergies and liver differentiation. , 1990, Current opinion in cell biology.